Study: Don't Believe the Sarbox 'Smack'

Lora Bentley

A new study from Ohio State University and University of Toronto researchers concludes that the detrimental effect of Sarbanes-Oxley on U.S. stock markets is "overblown," according to BloggingStocks writer Tom Taulli. In fact, the research revealed that foreign companies listing in the U.S. still draw a premium from their investors -- presumably in exchange for meeting the strict listing requirements. There is no evidence, the authors say, that Sarbox has harmed the U.S. exchanges.

 

Research notwithstanding, Taulli advises, don't expect private equity firms to ease up on knocking Sarbox. After all, studies like this one don't get much ink.



Add Comment      Leave a comment on this blog post

Post a comment

 

 

 

 


(Maximum characters: 1200). You have 1200 characters left.

 

null
null

 

Subscribe to our Newsletters

Sign up now and get the best business technology insights direct to your inbox.